No Data
Shares of Insurance and Reinsurance Companies Are Trading Lower Amid Sympathy With Progressive After That Company Reported Q2 Financial Results That Included Weak Policies-in-force and Underwriting Margins.
JP Morgan Maintains Neutral on Reliance, Lowers Price Target to $376
Barclays Maintains Equal-Weight on Exelixis, Raises Price Target to $49
The Art of the Toll: Risks of Trump's Plan to Charge for Hormuz Security
Wells Fargo Maintains Equal-Weight on Exelixis, Raises Price Target to $49
Top Consumer Staples Stocks Entering Q2 Earnings Season, Ranked by EPS Revisions